Sanjay Kalra and Silver Bahendeka, East Africa Diabetes Study Group Chair, provide an overview of the latest insulin guidance developed to aid management in a challenging region, facing familiar struggles.
Researchers studying the ARIC cohort have found that virtually all people with elevated fasting plasma glucose and glycated hemoglobin in the same blood sample went on to develop diabetes.
Editorial Board member Lori Berard talks through the stages and challenges associated with preparing type 2 diabetes patients for insulin therapy (9:00).
Researchers studying the ARIC cohort have found that virtually all people with elevated fasting plasma glucose and glycated hemoglobin in the same blood sample went on to develop diabetes.
Once-weekly dulaglutide lowers glycated hemoglobin levels to a similar degree to titrated daily insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease, study findings indicate.
